$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The goal of this protocol is to allow bedside providers to rapidly evaluate patients for intracranial hypertension in a non-invasive fashion using point-of-care ultrasound. In recent years, bedside decision-making and treatment have been augmented by the emergence of point-of-care ultrasound (POCUS). POCUS involves the use of ultrasound for diagnostic or procedural guidance by a patient's primary treatment provider. This article focuses on the diagnostic POCUS of the optic nerve sheath.
The rationale behind this technique is that the optic nerve and sheath communicate with the central nervous system. Specifically, the subarachnoid space extends from inside the skull around the optic nerve. Thus, when the intracranial pressure increases, the optic nerve sheath increases in size. It has been shown in studies with magnetic resonance imaging (MRI) and computed tomography (CT) that the optic nerve does not change in size with increased ICP, but the optic nerve sheath does. The vitreous of the eye provides excellent transmission of sound waves, resulting in the optic nerve being clearly visible as a hypoechoic structure inserted on the posterior eye, with the sheath visible around it. For these reasons, ultrasound of the optic nerve sheath has been used to detect elevated ICP, thus allowing the diagnosis of potentially life-threatening instances of increased ICP1.
However, despite its clinical significance, the proficiency of physicians in using ONSD POCUS is variable2,3, which limits the appropriate use of this modality4. This study aims to describe a time-efficient yet thorough image acquisition protocol for diagnostic ONSD POCUS and to illustrate the abnormal findings commonly found in clinical practice. Multiple imaging protocols have been described in the literature, and they present variations in the structural interpretation, ultrasound settings, marker placement, and scan technique5. Different marker points have varying sensitivity to changes in ICP, and the placement affects the ability to distinguish between patients with normal and high ICP. For these reasons, in this paper, we outline a standard technique to obtain optic nerve sheath images and measure them consistently.
Differences in the measurement location and technique have resulted in widely different thresholds of what is considered to be an abnormal optic nerve sheath5,6. In a recent meta-analysis, the average ONSD for patients without intracranial hypertension was 4.1 mm, and the average ONSD for those with increased ICP was 5.6 mm. A generally accepted threshold for a dilated ONSD is 5.5 mm, but a change in ONSD from a normal baseline is much more predictive if a baseline is available. In the context of severe TBI, the ONSD of both eyes seems to change together7. There are some individual cases of increased ONSD on one side, but this is rare8.
There are additional challenges in the measurement of ONSD in the severe traumatic brain injury (TBI) population. Patients with severe TBI (defined as having a Glasgow coma score of <8) are not alert enough to follow commands. This means a different approach is required to measure the nerve in this population compared to in patients being evaluated in an ophthalmology office in an elective fashion for neuritis. An A-scan can be used to measure the optic nerve in a cooperative patient that can hold their eye still for a length of time, but this is not a useful technique in TBI patients, so a B-scan is the standard technique (see step 2.7 below).
The use of this method and protocol should be considered for patients for whom there are concerns regarding intracranial hypertension but who do not have an intracranial monitor in place. Specific patient populations that may benefit are trauma patients with a clinical concern for traumatic brain injury in the prehospital or emergency room setting. Additionally, patients in the ICU with a sudden change in neurologic status are good candidates for ONSD POCUS.